Venture Capital Predicts the Future
From Genentech’s advances in biotechnology to Moderna’s COVID-19 vaccine, venture capital has long had a transformative influence on healthcare. Investors willing to put money on the table often have the most clear-eyed vision of the next big thing and in 2021, they poured more than $28 billion into the healthcare industry, almost doubling the previous year’s investments. Disruptive ideas are bubbling up in digital health and biopharmaceuticals, accelerating the shift of care away from clinical settings and into the home while promising to transform patient outcomes and overcome access gaps. How do venture capitalists decide where to place their bets? What breakthroughs lie ahead?